FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/06/008849 [Registered on: 16/06/2017] Trial Registered Prospectively
Last Modified On: 20/02/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Homoeopathic treatment of low back pain after caesarean delivery 
Scientific Title of Study   The role of homoeopathic treatment in individuals suffering from backache following caesarean section 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Arunava Nath 
Designation  Postgraduate Trainee 
Affiliation  National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India 
Address  OPD No. 5, Dept. of Organon of Medicine, National Institute of Homoeopathy, Block GE, Sector III, Salt Lake

Kolkata
WEST BENGAL
700106
India 
Phone  9339444585  
Fax    
Email  arunava_nath80@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Mahadeb De 
Designation  Reader, Dept. of Organon of Medicine 
Affiliation  National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India 
Address  Dept. of Organon of Medicine, National Institute of Homoeopathy, Block GE, Sector III, Salt Lake

Kolkata
WEST BENGAL
700106
India 
Phone  9831138007  
Fax    
Email  mail2mahadebde@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mahadeb De 
Designation  Reader, Dept. of Organon of Medicine 
Affiliation  National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India 
Address  Dept. of Organon of Medicine, National Institute of Homoeopathy, Block GE, Sector III, Salt Lake


WEST BENGAL
700106
India 
Phone  9831138007  
Fax    
Email  mail2mahadebde@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy, Ministry of AYUSH, Govt of India; Block GE, Sector III, Salt Lake, Kolkata 700106, West Bengal, India 
 
Primary Sponsor  
Name  National Institute of Homoeopathy Ministry of AYUSH Govt of India 
Address  Block GE, Sector III, Salt Lake, Kolkata 700106, West Bengal, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Arunava Nath  National Institute of Homoeopathy, Govt. of India  OPD Room no. 5, Dept. of Organon of Medicine, National Institute of Homoeopathy, Block GE, Sector III, Salt Lake, Kolkata 700106, India; Monday to Saturday, 9 am to 2 pm
Kolkata
WEST BENGAL 
9339444585

arunava_nath80@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Backache following caesarean section, (1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized homeopathic medicine in centesimal or 50 millesimal potencies  In centesimal potencies, each dose shall consist of 4 cane sugar globules medicated with a single drop of the indicated medicine, preserved in 88% v/v ethanol. In 50 millesimal potencies, a single medicated cane sugar globules of poppy seed size (no.10) dissolved in 50 ml distilled water with addition of 2 drops of 88% v/v ethanol, 10 doses marked on the vial, each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of the liquid in the cup. Repetition 24, 12 or 8 hourly or even oftener, depending upon the individual requirement of the case. Each dose to be taken orally on clean tongue in empty stomach. Duration of therapy: 3 months 
Comparator Agent  None  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1. Female patients suffering from backache over 3 months following caesarean section
2. Female subjects of reproductive age group of 18-45 years
3. Patients willing to take part in the study and giving written consent 
 
ExclusionCriteria 
Details  1. Patients who are too sick for consultation
2. Unable to read patient information sheets and not giving consent to take part
3. Postmenopausal women
4. Subjects presenting with confounding variable like pre-existing backache before Caesarean Section
5. Subjects with immediate complications after Caesarean Section
6. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life
7. Currently receiving homeopathic treatment for chronic condition(s)
8. Pregnant and lactating women
9. Self-reported immune-compromised state
10. Substance abuse and/or dependence 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Short form McGill Pain Questionnaire (SF-MPQ; translated Bengali version)  Baseline and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Oswestry Low Back Pain Questionnaire (translated Bengali version)  Baseline and 3 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/06/2017 
Date of Study Completion (India) 28/08/2018 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Nath A, De M, Singh S, Kundu N, Michael J, Sadhukhan S, et al. The role of homoeopathic treatment in women suffering from post-caesarean backache: An open observational clinical trial. Indian J Res Homoeopathy 2019;13:81-90. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  

Context: An open observational trial was carried out at National Institute of Homoeopathy, India, to assess the possible effects of individualised Homoeopathy in individuals suffering from post-caesarean backache. Aim: The aim of the study was to find the role of homoeopathic treatment in individuals suffering from post-caesarean backache. Methods: Fifty subjects were enrolled. The Short-Form McGill Pain Questionnaire (SF-MPQ) and Oswestry Low Back Pain Disability Questionnaire (ODQ) were used as the outcome measures, assessed at baseline and after 3 months of treatment. Medicines prescribed followed homoeopathic principles. Non-parametric Wilcoxon signed rank test was applied to compare the dependent observations. P < 0.05 two-tailed was considered statistically significant. Results: Five subjects dropped out and 45 completed the trial. Intention-to-treat sample (n = 50) was analysed. There were statistically significant reductions in pain rating index percentage score (median 83.3 (IQR 66.7 to 100) vs. median 66.7 (IQR 33.3 to 71.1), P < 0.001); visual analogue scale score (median 7.0 (IQR 6.0 to 8.0) vs. median 6.0 (IQR 4.8 to 7.0), P < 0.001); present pain index score (median 3.0 (IQR 2.0 to 3.0) vs. median 2.0 (IQR 2.0 to 3.0), P = 0.019) and ODQ% score (median 44.0 (IQR 39.5 to 50.0) vs. median 39.0 (IQR 31.9 to 44.0), P < 0.001) over 3 months of treatment. Natrum muriaticum (n = 11, 22%); Staphysagria (n = 8, 16%); Bryonia alba and Rhus toxicodendron (n = 6 each, 12%) and Pulsatilla nigricans (n = 4, 8%) were prescribed frequently. Conclusion: Indicated homoeopathic medicines reduced SF-MPQ and ODQ scores. Further randomised trials are warranted with enhanced methodological rigour.

 
Close